• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12B filed by Casper Sleep Inc.

    2/4/22 6:02:06 AM ET
    $CSPR
    Diversified Commercial Services
    Miscellaneous
    Get the next $CSPR alert in real time by email
    15-12B 1 brhc10033407_1512b.htm 15-12B

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 15

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
    OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-39214

    CASPER SLEEP INC.
    (Exact name of registrant as specified in its charter)

    Three World Trade Center
    175 Greenwich Street, Floor 40
    New York, New York 10007
    (347) 941-1871
    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
    Common Stock, $0.000001 Par Value Per Share
    (Title of each class of securities covered by this Form)
    None
    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
    Rule 12g-4(a)(1)
      ☒
    Rule 12g-4(a)(2)
     
    ☐
    Rule 12h-3(b)(1)(i)
     
    ☒
    Rule 12h-3(b)(1)(ii)
     
    ☐
    Rule 15d-6
     
    ☐
    Rule 15d-22(b)
     
    ☐
    Approximate number of holders of record as of the certification or notice date:
     
    Common Stock, par value $0.000001 per share: 1.*
     
    *On January 25, 2022, pursuant to an Agreement and Plan of Merger, dated November 14, 2021, by and among Casper Sleep Inc. (the “Company”), Marlin Parent Inc., a Delaware corporation (“Parent”), and Marlin Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), Merger Sub merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent.
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, Casper Sleep Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

       
    Casper Sleep Inc.
         
    Date: February 4, 2022
    By:
    /s/ Michael Monahan
       
    Name: Michael Monahan
       
    Title:   Chief Financial Officer and Secretary



    Get the next $CSPR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CSPR

    DatePrice TargetRatingAnalyst
    11/16/2021Buy → Neutral
    Guggenheim
    11/16/2021$9.50 → $6.90Buy → Neutral
    Citigroup
    11/10/2021$8.00 → $3.50Overweight → Neutral
    Piper Sandler
    10/25/2021Outperform → Neutral
    Wedbush
    8/11/2021$14.00 → $12.00Buy
    Roth Capital
    7/14/2021$7.00Sell
    Goldman Sachs
    More analyst ratings